Gout increases risk for COVID-19-related death

Patients with gout demonstrate an increased risk for COVID-19-related death, with a greater burden in those with female vs. male sex, according to data published in The Lancet Rheumatology.
“COVID-19 outcomes for people with inflammatory rheumatic disease are becoming increasingly available,” Ruth K. Topless, BSc, of the University of Otago, in New Zealand, and colleagues wrote. “Within a cohort of 3,729 patients with rheumatic disease, the COVID-19 Global Rheumatology Alliance identified hypertension associated with cardiovascular disease and chronic lung disease as a

Patients with gout demonstrate an increased risk for COVID-19-related death, with a greater burden in those with female vs. male sex, according to data published in The Lancet Rheumatology.
“COVID-19 outcomes for people with inflammatory rheumatic disease are becoming increasingly available,” Ruth K. Topless, BSc, of the University of Otago, in New Zealand, and colleagues wrote. “Within a cohort of 3,729 patients with rheumatic disease, the COVID-19 Global Rheumatology Alliance identified hypertension associated with cardiovascular disease and chronic lung disease as a